Larimar Therapeutics, Inc. (LRMR)
USD 4.16
(-3.7%)
USD 4.16
(-3.7%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -33.45 Million | -27.56 Million | -42.1 Million | -42.19 Million | -22.69 Million | -51.48 Million |
| Net Income | -36.94 Million | -35.35 Million | -50.63 Million | -42.48 Million | -23.13 Million | -61.36 Million |
| Depreciation & Amortization | 311 Thousand | 318 Thousand | 326 Thousand | 155 Thousand | 78 Thousand | 261 Thousand |
| Deferred income taxes | -8.63 Million | - | - | - | 3.63 Million | -9.62 Million |
| Stock-based compensation | 7.61 Million | 6.61 Million | 5.47 Million | 2.16 Million | 129 Thousand | 173 Thousand |
| Change in working capital | -2.51 Million | 1.66 Million | 2.74 Million | -2.04 Million | 226 Thousand | 593 Thousand |
| Other non-cash items | 6.71 Million | -820 Thousand | -15 Thousand | 10 Thousand | -3.63 Million | 9.78 Million |
| Investing Cash Flow | 33.35 Million | -90.96 Million | 24.16 Million | 17.09 Million | -83 Thousand | -6.86 Million |
| Investments in PPE | -164 Thousand | -100 Thousand | -333 Thousand | -62 Thousand | -83 Thousand | -108 Thousand |
| Acquisitions | -33.51 Thousand | 90.86 Thousand | -24.5 Thousand | -1.29 Million | -26.02 Million | 6.75 Million |
| Investment purchases | -101.23 Million | -133.61 Million | -8.24 Million | -24.48 Million | -82.86 Million | -117.14 Million |
| Sales/Maturities of investments | 134.75 Million | 42.75 Million | 32.75 Million | 1 Million | 109.47 Million | 110.38 Million |
| Other Investing Activities | 33.51 Thousand | -90.86 Thousand | 24.5 Thousand | 41.93 Million | -583 Thousand | -6.75 Million |
| Financing Cash Flow | 30 Thousand | 75.25 Million | 19.88 Million | 93.58 Million | 19.39 Million | 66.9 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | 67.22 Million |
| Common Stock Issuance | 30 Thousand | 75.25 Million | 19.88 Million | 75.59 Million | 19.39 Million | 66.9 Million |
| Other Financing Activities | 30.00 | 75.25 Thousand | 19.88 Thousand | 17.99 Million | 19.39 Million | 12.08 Million |
| Accounts receivables | - | - | - | - | 1.28 Million | -666 Thousand |
| Accounts payables | -403 Thousand | 26 Thousand | -974 Thousand | -3.28 Million | 2.63 Million | 432 Thousand |
| Inventory | - | - | - | - | -1.28 Million | - |
| Other working capital | -2.1 Million | 1.64 Million | 3.72 Million | 1.24 Million | -2.4 Million | 827 Thousand |
| Cash at beginning of period | 26.82 Million | 71.43 Million | 69.48 Million | 1 Million | 4.39 Million | 40.77 Million |
| Cash at end of period | 26.74 Million | 28.16 Million | 71.43 Million | 69.48 Million | 1 Million | 49.33 Million |
| Capital Expenditure | -164 Thousand | -100 Thousand | -333 Thousand | -62 Thousand | -83 Thousand | -108 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -76 Thousand | -43.27 Million | 1.94 Million | 68.47 Million | -3.38 Million | 8.55 Million |
| Free Cash Flow | -33.62 Million | -27.66 Million | -42.43 Million | -42.26 Million | -22.78 Million | -51.59 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -15.49 Million | -21.62 Million | -14.65 Million | -36.94 Million | -12.99 Million | -9.06 Million |
| Depreciation & Amortization | 74 Thousand | 87 Thousand | 80 Thousand | 311 Thousand | 81 Thousand | 76 Thousand |
| Deferred income taxes | - | - | - | -8.63 Million | -1.55 Million | -565 Thousand |
| Stock-based compensation | 1.95 Million | 2.3 Million | 2.12 Million | 7.61 Million | 1.91 Million | 1.82 Million |
| Change in working capital | -9.31 Million | 7.07 Million | 2.66 Million | -2.51 Million | 2.3 Million | -1.46 Million |
| Other non-cash items | -1.75 Million | -682 Thousand | 1.37 Million | 6.71 Million | 896 Thousand | -7000.00 |
| Investing Cash Flow | 27.27 Million | -63.49 Million | -68.36 Million | 33.35 Million | -2.62 Million | -46.43 Million |
| Investments in PPE | -62 Thousand | -274 Thousand | - | -164 Thousand | -164 Thousand | - |
| Acquisitions | - | - | - | -33.51 Thousand | 2465.00 | - |
| Investment purchases | -22.66 Million | -81.71 Million | -84.86 Million | -101.23 Million | -34.96 Million | -56.42 Million |
| Sales/Maturities of investments | 50 Million | 18.5 Million | 16.5 Million | 134.75 Million | 32.5 Million | 9.99 Million |
| Other Investing Activities | - | -63.21 Million | -68.36 Million | 33.51 Thousand | -2465.00 | -46.43 Thousand |
| Financing Cash Flow | 30 Thousand | -334 Thousand | 162.15 Million | 30 Thousand | - | 30 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 334 Thousand | -334 Thousand | - | - | - | - |
| Common Stock Issuance | -161.81 Million | -334 Thousand | 162.15 Million | 30 Thousand | - | 30 Thousand |
| Other Financing Activities | 30 Thousand | 11 Thousand | 162.15 Million | 30.00 | - | 30.00 |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -1.22 Million | 1.33 Million | 290 Thousand | -403 Thousand | 527 Thousand | -1.58 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -8.09 Million | 5.73 Million | 2.37 Million | -2.1 Million | 1.78 Million | 127 Thousand |
| Cash at beginning of period | 33.65 Million | 110.12 Million | 26.74 Million | 26.82 Million | 38.72 Million | 95.66 Million |
| Cash at end of period | 36.4 Million | 32.31 Million | 110.12 Million | 26.74 Million | 26.74 Million | 40.06 Million |
| Capital Expenditure | -62 Thousand | -274 Thousand | - | -164 Thousand | -164 Thousand | - |
| Effect of forex changes on cash | - | - | - | - | - | 55.54 Million |
| Net cash flow / Change in cash | 2.75 Million | -77.81 Million | 83.37 Million | -76 Thousand | -11.97 Million | -55.6 Million |
| Free Cash Flow | -24.6 Million | -14.26 Million | -10.41 Million | -33.62 Million | -9.5 Million | -9.2 Million |
3808
7444
BAK
NDSN
RGP
ECPG